These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 214218)

  • 41. Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.
    Kudo M; Ueshima K; Yokosuka O; Ogasawara S; Obi S; Izumi N; Aikata H; Nagano H; Hatano E; Sasaki Y; Hino K; Kumada T; Yamamoto K; Imai Y; Iwadou S; Ogawa C; Okusaka T; Kanai F; Akazawa K; Yoshimura KI; Johnson P; Arai Y;
    Lancet Gastroenterol Hepatol; 2018 Jun; 3(6):424-432. PubMed ID: 29631810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trial.
    Chlebowski RT; Hestorff R; Sardoff L; Weiner J; Bateman JR
    Cancer; 1978 Dec; 42(6):2546-52. PubMed ID: 365313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
    Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination chemotherapy of metastatic breast cancer: a randomized trial comparing the use of adriamycin to that of Vinblastine.
    Bezwoda WR; de Moor NG; Derman D; Lange M; Saner R; Dando R
    Cancer; 1979 Aug; 44(2):392-7. PubMed ID: 383254
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adriamycin in the treatment of resectible and irresectible primary hepatocellular carcinoma.
    Oon CJ; Chua EJ; Foong WC; Tan LK; Yo SL; Chang CH; Ho ST; Seah CS
    Ann Acad Med Singap; 1980 Apr; 9(2):256-9. PubMed ID: 6252816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
    J Gastroenterol; 2005 Jan; 40(1):70-8. PubMed ID: 15692792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 5-Fluorouracil plus high dose levofolinic acid and oral hydroxyurea for the treatment of primary hepatocellular carcinomas: results of a phase II multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Maiello E; Serravezza G; Giotta F; Testa A; Borsellino N; Pezzella G; Colucci G
    Anticancer Res; 1999; 19(2B):1407-10. PubMed ID: 10365114
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and chemotherapeutic study of hepatocellular carcinoma in Malaysia: a comparison with African and American patients.
    Joishy SK; Bennett JM; Balasegaram M; MacIntyre JM; Falkson G; Moertel C; Carbone PP
    Cancer; 1982 Sep; 50(6):1065-9. PubMed ID: 6286085
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of elderly patients with hepatocellular carcinomas with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1797-800. PubMed ID: 6307175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combination chemotherapy in advanced gastrointestinal malignancy.
    Vaughn CB; Brady P; Chinn BJ; Daversa GC; Parzuchowski JS
    Oncology; 1980; 37(1):57-61. PubMed ID: 6985729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized, phase II study comparing interferon combined with hepatic arterial infusion of fluorouracil plus cisplatin and fluorouracil alone in patients with advanced hepatocellular carcinoma.
    Yamashita T; Arai K; Sunagozaka H; Ueda T; Terashima T; Yamashita T; Mizukoshi E; Sakai A; Nakamoto Y; Honda M; Kaneko S
    Oncology; 2011; 81(5-6):281-90. PubMed ID: 22133996
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
    Engstrom PF; MacIntyre JM; Mittelman A; Klaassen DJ
    Am J Clin Oncol; 1984 Aug; 7(4):313-8. PubMed ID: 6377866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
    Hortobagyi GN; Gutterman JU; Blumenschein GR; Tashima CK; Burgess MA; Einhorn L; Buzdar AU; Richman SP; Hersh EM
    Cancer; 1979 Nov; 44(5):1955-62. PubMed ID: 387212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multi-drug chemotherapy with and without radiation for carcinoma of the stomach and pancreas: a prospective randomized trial.
    Hazel JJ; Thirlwell MP; Huggins M; Maksymiuk A; MacFarlane JK
    J Can Assoc Radiol; 1981 Sep; 32(3):164-5. PubMed ID: 7028759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275).
    Engstrom PF; Lavin PT; Douglass HO; Brunner KW
    Cancer; 1985 May; 55(9):1868-73. PubMed ID: 3884131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases.
    Yang TS; Chang HK; Chen JS; Lin YC; Liau CT; Chang WC
    J Gastroenterol; 2004; 39(4):362-9. PubMed ID: 15168248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of advanced gastric carcinoma with 5-fluorouracil: a randomized comparison of two routes of delivery.
    Chlebowski RT; Paroly WS; Pugh RP; Weiner JM; Bateman JR
    Cancer Treat Rep; 1979; 63(11-12):1979-81. PubMed ID: 393383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hepatic arterial chemotherapy combined with hyperthermia or arterial embolization in unresectable liver tumor].
    Hamazoe R; Koga S; Maeda M; Shimizu N; Shimizu T; Sawata T; Ishiguro M; Inoue Y; Wakatsuki T; Murakami A
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2590-5. PubMed ID: 2843128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intraaterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma: a clinical and pharmacology report.
    Bern MM; McDermott W; Cady B; Oberfield RA; Trey C; Clouse ME; Tullis JL; Parker LM
    Cancer; 1978 Aug; 42(2):399-405. PubMed ID: 209882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemotherapy of large intestinal carcinoma. Current results and future prospects.
    Schein PS; Kisner D; MacDonald JS
    Cancer; 1975 Dec; 36(6 Suppl):2418-20. PubMed ID: 764960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.